CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Immix Biopharma prices $125M stock offering

Neutral
AI Analysis

Summary

Immix Biopharma priced a $125 million stock offering to raise capital for operations and development.

Importance:5/10
Sentiment:
0.00
capital_raiseequity_offeringbiotech_financing

Read the original article

Published by Seeking Alpha Healthcare on September 29, 2026 11:33 AM

Read Original